trending Market Intelligence /marketintelligence/en/news-insights/trending/mcc1zjfxygta-fww9wxdsw2 content esgSubNav
In This List

OncBioMune Pharmaceuticals appoints director

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector

Blog

Insight Weekly: Energy reforms after midterms; Crisis ends 'age of gas'; bank deposits fall


OncBioMune Pharmaceuticals appoints director

OncBioMune Pharmaceuticals Inc. added Neal Holcomb to its board.

Holcomb is president and owner of Holcomb CPA Firm P.A. and serves as a director at several private companies. He was also the certified public accountant for OncBioMune LLC, before the company went public.

Baton Rouge, La.-based OncBioMune Pharmaceuticals is developing proprietary cancer vaccine technology and targeted cancer therapies.